Accuracy of 2D shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis C

  • Tamami Abe
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan
  • Hidekatsu Kuroda
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan
  • Yudai Fujiwara
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan
  • Yuichi Yoshida
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan
  • Akio Miyasaka
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan
  • Naohisa Kamiyama
    Ultrasound General Imaging GE Healthcare Tokyo, 191‐8503 Japan
  • Yasuhiro Takikawa
    Division of Hepatology, Department of Internal Medicine Iwate Medical University Morioka Iwate, 020‐8505 Japan

書誌事項

公開日
2018-04-06
資源種別
journal article
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/jcu.22592
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:sec><jats:title>Purpose</jats:title><jats:p>This prospective study was conducted to assess the diagnostic accuracy of two‐dimensional shear wave elastography (2D SWE) in the diagnosis of liver fibrosis in patients with chronic liver disease and hepatitis C virus (HCV) compared with the serum liver fibrosis biomarkers using the results of liver biopsy as the reference standard.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We analyzed 233 consecutive HCV patients. On the same day, 2D SWE m, biochemical tests, and liver biopsy were performed. We used the METAVIR staging system and receiver operating characteristic curves for the analysis.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The success rate of 2D‐SWE was 98.7%. The median shear wave velocities (SWVs) of patients in the F0, F1, F2, F3, and F4 stages were 1.35 m/s, 1.42 m/s, 1.58 m/s, 1.83 m/s, and 2.13 m/s, respectively, demonstrating a stepwise increase (<jats:italic>P</jats:italic> < .0001). The accuracy of 2D‐SWE in the prediction of ≥F1, ≥F2, ≥F3, and F4 was .888 (95% CI: .85‐.93), .915 (95% CI: .88‐095), .940 (95% CI: .91‐.97), and .949 (95% CI: .92‐.97), respectively. 2D‐SWE was significantly superior to serum liver fibrosis biomarkers.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>2D‐SWE was positively correlated with the severity of liver fibrosis and was more useful for to predict all liver fibrosis grades in HCV patients than liver fibrosis biomarkers.</jats:p></jats:sec>

収録刊行物

被引用文献 (3)*注記

もっと見る

参考文献 (38)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ